BioGend Therapeutics Co., Ltd. (TPEX:6733)
30.75
-0.35 (-1.13%)
Apr 17, 2026, 1:30 PM CST
15.82% (1Y)
| Market Cap | 3.82B -3.4% |
| Revenue (ttm) | 222.34M +32.6% |
| Net Income | -84.61M |
| EPS | -0.69 |
| Shares Out | 124.36M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 305,721 |
| Average Volume | 199,518 |
| Open | 31.10 |
| Previous Close | 31.10 |
| Day's Range | 30.40 - 31.10 |
| 52-Week Range | 25.50 - 49.15 |
| Beta | 0.28 |
| RSI | 27.10 |
| Earnings Date | May 8, 2026 |